Shipments of Pfizer vaccines will begin the largest vaccination effort in American history during a critical period of the pandemic, which killed 1.6 million people and killed 71 million people worldwide.
Initially, about 3 million doses are expected, and the surge in infectious diseases, hospitalizations, and deaths in the United States will prioritize healthcare professionals and nursing home residents, which could worsen during vacations. The vaccine is a spot to fight the pandemic that killed nearly 300,000 bright Americans.
According to federal authorities, the first shipments of Pfizer vaccines will be staggered, arriving at 145 distribution centers on Monday, 425 sites shipping on Tuesday, and the remaining 66 sites shipping Wednesday. The vaccine, co-developed by German partner BioNTech, is distributed based on the adult population of each state.
See: How Pfizer Distributes Millions of COVID-19 Vaccines to All 50 States in Two Days
Dr. Graham Snyder, who headed the Center’s Vaccine Task Force, said Pennsylvania’s healthcare giant UPMC has selected the staff essential to the operation of the facility from among the first vaccinated staff.
“It’s very exciting. The moment we administer the first dose, I’m thrilled,” Snyder said on Saturday. “It will obviously be a watershed moment for us.”
According to Snyder, the UPMC system estimates that half of its employees are ready to be vaccinated as soon as they are vaccinated.
Vaccines are heading to hospitals and other places where they can be stored at very low temperatures of about 94 degrees below freezing. Pfizer uses containers with dry ice and GPS-enabled sensors to keep each cargo cooler than the Antarctic weather.
According to federal authorities, doses should be delivered within 3 weeks to all state-specified vaccination sites, including local pharmacies.
The Oshner Health System at 40 hospitals in Louisiana and Mississippi expects to receive more than 9,000 doses in the next few days, said Dr. Sandrake Marie, hospital quality medical director.
She said the employee approved in the first round received a text and email instructing her to schedule her first injection.
“I think I’m enthusiastic,” Kemaly said on Saturday. “There is an idea that if you are vaccinated and have immunity, you may not have to be too afraid to come to work.”
This deployment ensures that people have enough vaccine to give people the two doses needed for complete protection against COVID-19. This means that the government is refraining from giving 3 million doses to those who were vaccinated in the first round to get a second vaccination a few weeks later.
The Food and Drug Administration approved the emergency use of the vaccine on Friday, saying it was very protective and had no major safety concerns. US regulators worked for months to emphasize the rigor and independence of the reviews, but faced political pressure until the final stages.
Concerns about rushing firing can undermine vaccination efforts in countries skeptical of vaccines. The FDA’s head said the authorities’ decisions were based on science, not politics, even though the White House threatened to dismiss him if the vaccine was not approved by Saturday.
Dr. Monsef Slawi, Chief Science Advisor for Operation Warp Speed, a U.S. effort to accelerate the development of vaccines, told Fox News on Sunday that he was “extremely concerned” about skepticism about vaccines in some circles. “.
“Unfortunately, there is so much politics related to the development of this vaccine, and people think we’ve cut corners on how thorough, scientific and factual the work done is. There was confusion with the perception that it was. ” “We can assure you that such a thing did not happen and that we obey science.”
He called the development of vaccines from several pharmaceutical companies, including Modern and AstraZeneca, “an amazing achievement of the scientific, academia, industry ecosystem, and the US government working together.”
Although the vaccine has been determined to be safe, UK regulators are investigating several severe allergic reactions. The FDA’s instructions urge providers not to give it to anyone with a known history of severe allergic reactions to any of its ingredients.
Another vaccine by Moderna will be reviewed by a panel of experts next week and may be approved for public use shortly thereafter.
Copyright © 2020 AP communication. all rights reserved.
First look: COVID-19 vaccine dose leaves Pfizer’s Michigan facility
Source link First look: COVID-19 vaccine dose leaves Pfizer’s Michigan facility